EVIDENCE FOR ALTERED CATALYTIC PROPERTIES OF THE CYTOCHROME-P-450 INVOLVED IN SPARTEINE OXIDATION IN POOR METABOLIZERS

被引：25

作者：

OSIKOWSKAEVERS, B

DAYER, P

MEYER, UA

ROBERTZ, GM

EICHELBAUM, M

机构：

[1] DR MARGARETE FISCHER BOSCH INST PHARMACOL,AUERBACHSTR 112,D-7000 STUTTGART 50,FED REP GER

[2] UNIV BONN,DEPT MED,D-5300 BONN,FED REP GER

[3] UNIV BASEL,BIOCTR,DEPT PHARMACOL,CH-4056 BASEL,SWITZERLAND

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1987年 / 41卷 / 03期

关键词：

D O I：

10.1038/clpt.1987.34

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：320 / 325

页数：6

共 23 条

[1] ANIMAL MODELING OF HUMAN POLYMORPHIC DRUG OXIDATION - THE METABOLISM OF DEBRISOQUINE AND PHENACETIN IN RAT INBRED STRAINS [J].

ALDABBAGH, SG ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (03) :161-164

[2]

BERTILSSON L, 1980, EUR J CLIN PHARM, V40, P275

[3]

BOOBIS AR, 1983, MOL PHARMACOL, V23, P474

[4] EVIDENCE FOR AN ENZYMATIC DEFECT IN THE 4-HYDROXYLATION OF DEBRISOQUINE BY HUMAN-LIVER [J].

DAVIES, DS ;

KAHN, GC ;

MURRAY, S ;

BRODIE, MJ ;

BOOBIS, AR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (01) :89-91

[5] CHARACTERIZATION OF A COMMON GENETIC-DEFECT OF CYTOCHROME-P-450 FUNCTION (DEBRISOQUINE-SPARTEINE TYPE POLYMORPHISM) - INCREASED MICHAELIS CONSTANT (KM) AND LOSS OF STEREOSELECTIVITY OF BUFURALOL 1'-HYDROXYLATION IN POOR METABOLIZERS [J].

DAYER, P ;

GASSER, R ;

GUT, J ;

KRONBACH, T ;

ROBERTZ, GM ;

EICHELBAUM, M ;

MEYER, UA .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 125 (01) :374-380

[6]

DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057

[7] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].

EICHELBAUM, M ;

SPANNBRUCKER, N ;

STEINCKE, B ;

DENGLER, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187

[8] THE GENETIC-POLYMORPHISM OF SPARTEINE METABOLISM [J].

EICHELBAUM, M ;

REETZ, KP ;

SCHMIDT, EK ;

ZEKORN, C .

XENOBIOTICA, 1986, 16 (05) :465-481

[9] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].

EICHELBAUM, M ;

BERTILSSON, L ;

SAWE, J ;

ZEKORN, C .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186

[10]

EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001

← 1 2 3 →